| Evidence‐based practice guidelines for plasma transfusion JD Roback, S Caldwell, J Carson, R Davenport, MJ Drew, A Eder, M Fung, ... Transfusion 50 (6), 1227-1239, 2010 | 369 | 2010 |
| Transfusion‐related acute lung injury surveillance (2003‐2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross AF Eder, R Herron, A Strupp, B Dy, EP Notari, LA Chambers, RY Dodd, ... Transfusion 47 (4), 599-607, 2007 | 281 | 2007 |
| Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004‐2006) AF Eder, JM Kennedy, BA Dy, EP Notari, JW Weiss, CT Fang, S Wagner, ... Transfusion 47 (7), 1134-1142, 2007 | 264 | 2007 |
| Adverse reactions to allogeneic whole blood donation by 16-and 17-year-olds AF Eder, CD Hillyer, BA Dy, EP Notari, RJ Benjamin Jama 299 (19), 2279-2286, 2008 | 202 | 2008 |
| Noninfectious complications of blood transfusion AF Eder, LA Chambers Archives of pathology & laboratory medicine 131 (5), 708-718, 2007 | 196 | 2007 |
| Effective reduction of transfusion‐related acute lung injury risk with male‐predominant plasma strategy in the American Red Cross (2006‐2008) AF Eder, RM Herron Jr, A Strupp, B Dy, J White, EP Notari, RY Dodd, ... Transfusion 50 (8), 1732-1742, 2010 | 192 | 2010 |
| The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006 AF Eder, BA Dy, JM Kennedy, EP Notari IV, A Strupp, ME Wissel, R Reddy, ... Transfusion 48 (9), 1809-1819, 2008 | 175 | 2008 |
| Autologous lymphapheresis for the production of chimeric antigen receptor T cells ES Allen, DF Stroncek, J Ren, AF Eder, KA West, TJ Fry, DW Lee, ... Transfusion 57 (5), 1133-1141, 2017 | 148 | 2017 |
| Limiting and detecting bacterial contamination of apheresis platelets: inlet‐line diversion and increased culture volume improve component safety AF Eder, JM Kennedy, BA Dy, EP Notari, R Skeate, G Bachowski, DC Mair, ... Transfusion 49 (8), 1554-1563, 2009 | 140 | 2009 |
| Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance) A Eder, M Goldman, S Rossmann, D Waxman, C Bianco Transfusion Medicine Reviews 23 (3), 205-220, 2009 | 117 | 2009 |
| Update on HDFN: new information on long-standing controversies AF Eder IMMUNOHEMATOLOGY-WASHINGTON DC- 22 (4), 188, 2006 | 111 | 2006 |
| TRANSFUSION COMPLICATIONS: Transfusion‐transmitted Babesia microti identified through hemovigilance L Tonnetti, AF Eder, B Dy, J Kennedy, P Pisciotto, RJ Benjamin, DA Leiby Transfusion 49 (12), 2557-2563, 2009 | 104 | 2009 |
| The residual risk of transfusion‐related acute lung injury at the A merican R ed C ross (2008‐2011): limitations of a predominantly male‐donor plasma mitigation strategy AF Eder, BA Dy, JM Perez, M Rambaud, RJ Benjamin Transfusion 53 (7), 1442-1449, 2013 | 100 | 2013 |
| Age‐related donor return patterns among first‐time blood donors in the United States EP Notari IV, S Zou, CT Fang, AF Eder, RJ Benjamin, RY Dodd Transfusion 49 (10), 2229-2236, 2009 | 94 | 2009 |
| Bacterial contamination of whole blood–derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross RJ Benjamin, L Kline, BA Dy, J Kennedy, P Pisciotto, S Sapatnekar, ... Transfusion 48 (11), 2348-2355, 2008 | 84 | 2008 |
| Measures to prevent transfusion‐related acute lung injury (TRALI) HW Reesink, J Lee, A Keller, P Dennington, J Pink, R Holdsworth, ... Vox sanguinis 3 (103), 231-259, 2012 | 83 | 2012 |
| 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium SL Spitalnik, D Triulzi, DV Devine, WH Dzik, AF Eder, T Gernsheimer, ... Transfusion 55 (9), 2282-2290, 2015 | 70 | 2015 |
| Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results RJ Benjamin, B Dy, J Perez, AF Eder, SJ Wagner Vox sanguinis 106 (1), 23-30, 2014 | 66 | 2014 |
| The entity of immunoglobulin A-related anaphylactic SG Sandler, AE Eder, M Goldman, JL Winters Transfusion 55, 2015 | 65 | 2015 |
| Skin disinfection with a single‐step 2% chlorhexidine swab is more effective than a two‐step povidone‐iodine method in preventing bacterial contamination of apheresis platelets RJ Benjamin, B Dy, R Warren, M Lischka, AF Eder Transfusion 51 (3), 531-538, 2011 | 61 | 2011 |
